Skip to main content
Journal cover image

Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction.

Journal articles  - Journal Article
Brownell, N; Solomon, N; Greene, SJ; Chiswell, K; Vaduganathan, M; Yancy, C; Hsue, P; Ziaeian, B; Fonarow, GC
Published in: J Am Heart Assoc
May 19, 2026

BACKGROUND: SGLT2 (sodium-glucose cotransporter-2) inhibitors (SGLT2i) reduce cardiovascular events in randomized controlled trials of patients with heart failure with reduced ejection fraction (HFrEF), but these trials enrolled outpatient, relatively younger patients (median age 66-67). The effectiveness of SGLT2i in older patients hospitalized for HFrEF in routine US clinical practice is not well studied. METHODS: This study included Medicare beneficiaries aged ≥65 years hospitalized for HFrEF and eligible for SGLT2i in Get with the Guidelines-Heart Failure between July 1, 2021 and June 30, 2023. Primary outcomes were 30-day and 1-year all-cause mortality, all-cause readmission, and HF readmission. Association between SGLT2i and outcomes was assessed with Cox regression and overlap weighting using propensity score estimates. RESULTS: A total of 8847 patients were eligible for but not prescribed SGLT2i at hospital admission (Median age 77; 40% women; median left ventricular EF 28%); 1464 (16.5%) patients were initiated on SGLT2i by discharge. After overlap weighting, SGLT2i initiation was independently associated with lower all-cause mortality (adjusted hazard ratio [HR], 0.76 [95% CI, 0.67-0.86]), all-cause readmission (HR, 0.89 [95% CI, 0.81-0.97]), and HF readmission (HR, 0.84 [95% CI, 0.75-0.95]) over 12-month follow-up, compared with those not prescribed SGLT2i. Findings were consistent across subgroups based on age, sex, race, ethnicity, diabetes status, chronic kidney disease status, and left ventricular EF. CONCLUSIONS: Among older patients hospitalized for HFrEF, SGLT2i initiation by time of discharge was independently associated with reduced all-cause mortality, all-cause readmission, and HF readmission. These findings support SGLT2i use to improve postdischarge outcomes among older patients hospitalized for HFrEF in routine US practice.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

May 19, 2026

Volume

15

Issue

10

Start / End Page

e049161

Location

England

Related Subject Headings

  • Ventricular Function, Left
  • United States
  • Treatment Outcome
  • Stroke Volume
  • Sodium-Glucose Transporter 2 Inhibitors
  • Patient Readmission
  • Male
  • Humans
  • Hospitalization
  • Heart Failure
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brownell, N., Solomon, N., Greene, S. J., Chiswell, K., Vaduganathan, M., Yancy, C., … Fonarow, G. C. (2026). Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc, 15(10), e049161. https://doi.org/10.1161/JAHA.126.049161
Brownell, Nicholas, Nicole Solomon, Stephen J. Greene, Karen Chiswell, Muthiah Vaduganathan, Clyde Yancy, Priscilla Hsue, Boback Ziaeian, and Gregg C. Fonarow. “Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction.J Am Heart Assoc 15, no. 10 (May 19, 2026): e049161. https://doi.org/10.1161/JAHA.126.049161.
Brownell N, Solomon N, Greene SJ, Chiswell K, Vaduganathan M, Yancy C, et al. Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2026 May 19;15(10):e049161.
Brownell, Nicholas, et al. “Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction.J Am Heart Assoc, vol. 15, no. 10, May 2026, p. e049161. Pubmed, doi:10.1161/JAHA.126.049161.
Brownell N, Solomon N, Greene SJ, Chiswell K, Vaduganathan M, Yancy C, Hsue P, Ziaeian B, Fonarow GC. Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2026 May 19;15(10):e049161.
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

May 19, 2026

Volume

15

Issue

10

Start / End Page

e049161

Location

England

Related Subject Headings

  • Ventricular Function, Left
  • United States
  • Treatment Outcome
  • Stroke Volume
  • Sodium-Glucose Transporter 2 Inhibitors
  • Patient Readmission
  • Male
  • Humans
  • Hospitalization
  • Heart Failure